<DOC>
	<DOC>NCT00299806</DOC>
	<brief_summary>Assessing the safety and efficacy of SPP100 (Aliskiren) regimen in patients with severe hypertension</brief_summary>
	<brief_title>SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Age: 20 80 years old Gender: Male or female Status: Outpatients severe hypertension Patients with a clinically significant allergy Patients who have received other investigational drug Alcoholic patients Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hypertension, aliskiren, blood pressure, rennin</keyword>
</DOC>